Helix Nanotechnologies Patents

Patent portfolio assigned to Helix Nanotechnologies (verified via public assignee records). Estimated patent count: 2. US (Boston) biotech building a next-gen mRNA therapeutic platform. Has patents: USPTO-granted US 12,343,392 (fusion polypeptides / mRNA) and US 12,215,317 (modified ribonucleotides), per Justia assignee listing and Yes VC announcement of a granted foundational mRNA chemistry patent. No competitors or named customers confirmed (Aug 2025 MOU with Medicus Pharma is a partner/collaboration, not a customer).